Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India orders, deals and press releases
47 filed, newest first.
Apr 2026
Aug 2025
May 2025
Feb 2025
Jul 2024
Jun 2024
May 2024
Oct 2023
May 2023
Jun 2020
Sep 2019
Feb 2019
Jan 2019
Oct 2018
Sep 2018
Jun 2018
Feb 2018
Dec 2017
Oct 2017
Sep 2017
Nov 2016
Jun 2016
Mar 2016
Dec 2015
Nov 2015
Oct 2015
Aug 2014
Apr 2014
Nov 2013
Sep 2013
Aug 2013
Feb 2013
Oct 2012
Aug 2011
Nov 2010
Dec 2009
10 Dec · Business
Press release dated December 10, 2009, titled "Sanofi-aventis launches PRAYAS, an endeavor to meet rural India's healthcare needs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
28 Jul · Business
Vide its letter dated July 24, 2009 regarding a press release issued by sanofi-aventis of France (the ultimate holding company of the Company), dated July 23, 2009, titled "CHMP confirms the safety of Lantus ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Business
Vide its letter dated July 16, 2009 regarding a press release issued by sanofi-aventis of France (the ultimate holding company of the Company), dated July 15, 2009, titled "Expert Statement Issued about Lantus following recent publications in Diabetologia". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
30 Jun · Business
Vide its letter dated June 30, 2009 regarding a press release issued by sanofi-aventis of France (the ultimate holding company of the Company), dated June 26, 2009, titled "Sanofi-aventis stands behind the safety of Lantus ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
2 May · Business
Press release dated April 29, 2008, titled "Sanofi-aventis launches SoloSTAR(R)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
26 Jul · Business
Press release dated July 26, 2007, titled "Aventis Pharma Limited (SANOFI-AVENTIS GROUP) and Themis Laboratories Pvt. Ltd. Sign Technology Transfer Deal". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jul · Business
Press release dated July 18, 2007, titled "Aventis Pharma Limited- Sales and Profit for Q2 2007 and H1 2007". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
17 Apr · Business
Media release dated April 16, 2007, titled "Aventis Pharma Limited announces its Sales and Profit for Q1 2007". The details of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2007
26 Mar · Business
Media release dated March 26, 2007, titled "Aventis Pharma Limited announces its Sales and Profit for 2006". The details of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.